![]() Use the PitchBook Platform to explore the full profile. These companies include Seres Therapeutics (NASDAQ:MCRB), Moderna (MRNA), Syros Pharmaceuticals (SYRS), Rubius Therapeutics (RUBY), Axcella Health (AXLA), Evelo Biosciences (EVLO), and Indigo Agriculture. Information on valuation, funding, cap tables, investors, and executives for Tessera Therapeutics. Flagship Pioneering has created over 40 groundbreaking companies over the past fifteen years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. Tessera Therapeutics was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Gene Writing is a new biotechnology that writes therapeutic messages into the genome to cure thousands of diseases at their source. On Friday, Tessera Therapeutics announced preliminary data from five preclinical programs using its gene writers to tweak specific letters or insert entirely new sequences of DNA. Gene Editing biotechnologies heralded the era of genome-modifying medicines, but they cannot address most diseases. Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large. Tessera Therapeutics was founded in 2018 by Flagship Pioneering, a life sciences innovation enterprise that conceives, creates, resources, and develops first-in-category bioplatform companies to. Our genome is a mosaic comprising genes that protect us from, predispose us to, and cause disease. Tessera Therapeutics is pioneering Gene Writing to cure disease.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |